Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 351

1.

Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma.

Bassily NH, Vallorosi CJ, Akdas G, Montie JE, Rubin MA.

Am J Clin Pathol. 2000 Mar;113(3):383-8.

PMID:
10705819
2.

Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.

Chuang AY, DeMarzo AM, Veltri RW, Sharma RB, Bieberich CJ, Epstein JI.

Am J Surg Pathol. 2007 Aug;31(8):1246-55.

PMID:
17667550
3.

Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma.

Genega EM, Hutchinson B, Reuter VE, Gaudin PB.

Mod Pathol. 2000 Nov;13(11):1186-91.

4.

Immunohistochemical profile of high-grade urothelial bladder carcinoma and prostate adenocarcinoma.

Mhawech P, Uchida T, Pelte MF.

Hum Pathol. 2002 Nov;33(11):1136-40.

PMID:
12454820
5.

Primary seminal vesicle carcinoma: an immunohistochemical analysis of four cases.

Ormsby AH, Haskell R, Jones D, Goldblum JR.

Mod Pathol. 2000 Jan;13(1):46-51.

6.
7.
8.

[Coordinated expression of cytokeratin 7 and 20 in transitional carcinoma of the bladder: diagnostic usefulness].

Cid Mouteira P, Ortíz Rey JA, Antón Badiola I, San Miguel Fraile P, Alvarez Alvarez C, Zungri Telo E, de la Fuente Buceta A.

Actas Urol Esp. 2002 Apr;26(4):279-84. Spanish.

PMID:
12090187
9.
11.
12.

The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.

Sheridan T, Herawi M, Epstein JI, Illei PB.

Am J Surg Pathol. 2007 Sep;31(9):1351-5.

PMID:
17721190
14.

Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.

Christoph F, Müller M, Schostak M, Soong R, Tabiti K, Miller K.

Urology. 2004 Jul;64(1):157-61.

PMID:
15245962
15.

Poorly differentiated adenocarcinomas of prostate versus high-grade urothelial carcinoma of the bladder: a diagnostic dilemma with immunohistochemical evaluation of 2 cases.

Martínez-Rodríguez M, Ramos D, Soriano P, Subramaniam M, Navarro S, Llombart-Bosch A.

Int J Surg Pathol. 2007 Apr;15(2):213-8.

PMID:
17478786
16.

Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder.

Lane Z, Hansel DE, Epstein JI.

Am J Surg Pathol. 2008 Sep;32(9):1322-6. doi: 10.1097/PAS.0b013e3181656ca0.

PMID:
18670358
17.

Immunohistochemical expression of cytokeratins 7 and 20 in malignant salivary gland tumors.

Nikitakis NG, Tosios KI, Papanikolaou VS, Rivera H, Papanicolaou SI, Ioffe OB.

Mod Pathol. 2004 Apr;17(4):407-15.

18.
19.

Cytokeratin 20: a new marker for early detection of bladder cell carcinoma?

Buchumensky V, Klein A, Zemer R, Kessler OJ, Zimlichman S, Nissenkorn I.

J Urol. 1998 Dec;160(6 Pt 1):1971-4.

PMID:
9817302
20.

The androgen receptor revisited in urothelial carcinoma.

Birtle AJ, Freeman A, Munson P.

Histopathology. 2004 Jul;45(1):98-9. No abstract available.

PMID:
15228457

Supplemental Content

Support Center